JD Capital invests 80 million RMB in Guangxi Tianyuan Biochemical, enhancing its market position in the Chinese pesticide sector.
Information on the Target
The target of this investment is Guangxi Tianyuan Biochemical, one of the largest pesticide manufacturing companies in Southwest China. The company has recently attracted significant attention due to its strategic focus on the rice pesticide market, where it has established itself as a leading player. With an estimated sales revenue of 800 million RMB in 2008, Tianyuan’s growth trajectory seems promising as it continues to expand its market share, particularly in the context of a transforming agricultural industry in China.
Tianyuan Biochemical’s significant market presence is set against a backdrop of industry consolidation, especially after stringent regulatory changes that have pushed several smaller players out of the market. As a result, the company is positioned to capitalize on the growing demand for high-quality pesticide products, making it an appealing target for investment.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in China
The agricultural investment landscape in China has been evolving rapidly, especially following the global food crisis. The total investment in agriculture has risen remarkably from 640,000 USD in 2002 to
Similar Deals
Jiuding Capital → Huizhou Zhongxun Chemical Engineering Co., Ltd.
2023
SPE PEF III, Proparco, Amethis MENA Fund II → Delta Holdings B.V.
2025
Advantage Capital → United Metallurgical Equipment Companies of Cincinnati (UMECC)
2025
九鼎投资
invested in
广西田园生化
in 2009
in a Growth Equity & Expansion Capital deal
Disclosed details
Transaction Size: $1M
Revenue: $1M